Beta blockers, statins and recommended doses of ACE-I improve survival in non-randomized patients with heart failure. A propensity score analysis of the Norwegian Heart Failure Registry

被引:0
|
作者
De Blois, J. [1 ]
Fagerland, M. Wang [2 ]
Grundtvig, M. [3 ]
Gullestad, L. [4 ]
Westheim, A. [5 ]
Hole, T. [6 ]
Atar, D. [1 ]
Agewall, S. [1 ]
机构
[1] Univ Oslo, Fac Div Aker Univ Hosp, Dept Cardiol, Oslo, Norway
[2] Ullevaal Univ Hosp, Clin Res Ctr, Unit Epidemiol & Biostat, Oslo, Norway
[3] Innlandet Hosp Trust Lillehammer, Dept Med, Lillehammer, Norway
[4] Univ Oslo, Fac Div Rikshosp Univ Hosp, Dept Cardiol, Oslo, Norway
[5] Univ Oslo, Fac Div Ulleval Univ Hosp, Dept Cardiol, Oslo, Norway
[6] Alesund Hosp, Dept Internal Med, Alesund, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:847 / 847
页数:1
相关论文
共 50 条
  • [31] Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
    Al-Gobari, Muaamar
    El Khatib, Chadia
    Pillon, Francois
    Gueyffier, Francois
    BMC CARDIOVASCULAR DISORDERS, 2013, 13
  • [32] Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
    Muaamar Al-Gobari
    Chadia El Khatib
    François Pillon
    François Gueyffier
    BMC Cardiovascular Disorders, 13
  • [33] A retrospective analysis of major markers of heart failure severity in patients receiving both ACE inhibitors and beta-blockers in Val-HeFT
    Anand, IS
    Glazer, R
    Chiang, T
    Latini, R
    Maggioni, AP
    Hester, A
    Aknay, N
    Carson, P
    Tognoni, G
    Cohn, JN
    CIRCULATION, 2003, 108 (17) : 445 - 446
  • [34] Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers
    Flannery, Genevieve
    Gehrig-Mills, Rosie
    Billah, Baki
    Krum, Henry
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (06): : 865 - 869
  • [35] Impact of β-blockers on in-hospital mortality in patients with heart failure: a retrospective propensity-score matched analysis based on MIMIC-IV database
    Wang, Xin
    Zhang, Yuzhu
    Xia, Jiangling
    Xu, Hongyu
    Zhang, Lu
    Feng, Nianhai
    An, Xiaona
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [36] Beta-blockers improve survival in patients with heart failure regardless of renal function. An analysis of the Cardiac Insufficiency BIsoprolol Study II (CIBIS II) trial
    Castagno, D.
    Jhund, P. S.
    Mcmurray, J. J. V.
    Erdmann, E.
    Zannad, F.
    Remme, W. J.
    Lopez Sendon, J. L.
    Lechat, P.
    Dargie, H. J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 421 - 421
  • [37] Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis
    Turgeon, Ricky D.
    Kolber, Michael R.
    Loewen, Peter
    Ellis, Ursula
    McCormack, James P.
    PLOS ONE, 2019, 14 (02):
  • [38] Sacubitril/valsartan Vs Ace Inhibitor Use In Patients With Heart Failure With Reduced Ejection Fraction And New York Heart Association-4 Symptoms; A Propensity Score Matched Analysis
    Rawlley, Bharat
    Sanchez, Andres Cordova
    Chaudhuri, Debanik
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 154 - 154
  • [39] Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry (vol 22, pg 103, 2020)
    Stolfo, D.
    Uijl, A.
    Benson, L.
    Schrage, B.
    Fudim, M.
    Asselbergs, F. W.
    Koudstaal, S.
    Sinagra, G.
    Dahlstrom, U.
    Rosano, G.
    Savarese, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (07) : 1287 - 1287
  • [40] Beta-blocker therapy and in-hospital outcome in acute heart failure: a propensity-score matching secondary analysis of the ALARM-HF registry
    Farmakis, D. T.
    Parissis, J.
    Simitsis, P.
    Bistola, V.
    Ikonomidis, I.
    Papingiotis, G.
    Filippatos, G.
    Mebazaa, A.
    Lekakis, J.
    Follath, F.
    EUROPEAN HEART JOURNAL, 2015, 36 : 545 - 546